Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens

被引：17

作者：

Citron, DM

Warren, YA

Fernandez, HT

Goldstein, MA

Tyrrell, KL

Goldstein, EJC

机构：

[1] RM Alden Res Lab, Santa Monica, CA 90404 USA

[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90095 USA

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2005年 / 43卷 / 05期

关键词：

D O I：

10.1128/JCM.43.5.2485-2488.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Broth microdilution and disk diffusion susceptibility testing were performed on 73 strains of Pasteurella species isolated from human infections and on five American Type Culture Collection strains of Pasteurella species. Both methods appear reliable for testing susceptibilities of Pasteurella species.

引用

收藏

页码：2485 / 2488

页数：4

相关论文

共 18 条

[1]

[Anonymous], 2003, M2A8 NAT COMM CLIN L

[2]

[Anonymous], 2004, M100S14 NAT COMM CLI

[3] Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections [J].

Goldstein, EJC ;

Citron, DM ;

Merriam, CV ;

Warren, Y ;

Tyrrell, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2525-2529

[4] LACK OF INVITRO EFFICACY OF ORAL FORMS OF CERTAIN CEPHALOSPORINS, ERYTHROMYCIN, AND OXACILLIN AGAINST PASTEURELLA-MULTOCIDA [J].

GOLDSTEIN, EJC ;

CITRON, DM ;

RICHWALD, GA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (02) :213-215

[5]

GOLDSTEIN EJC, 1978, J CLIN MICROBIOL, V8, P667

[6] Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans [J].

Goldstein, EJC ;

Citron, DM ;

Gerardo, SH ;

Hudspeth, M ;

Merriam, CV .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) :1127-1132

[7] In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species [J].

Goldstein, EJC ;

Citron, DM ;

Merriam, CV ;

Warren, YA ;

Tyrrell, KL ;

Fernandez, HT .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) :3068-3070

[8] Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections [J].

Goldstein, EJC ;

Citron, DM ;

Merriam, CV ;

Tyrrell, K ;

Warren, Y .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1475-1479

[9] PASTEURELLA-MULTOCIDA ARTHRITIS - CASE-REPORT [J].

GOMEZREINO, JJ ;

SHAH, M ;

GOREVIC, P ;

LUSSKIN, R .

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1980, 62 (07) :1212-1213

[10] Need for susceptibility testing guidelines for fastidious or less-frequently isolated bacteria [J].

Jorgensen, JH .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (02) :493-496